首页 | 本学科首页   官方微博 | 高级检索  
     


Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation,open-label,non-randomised,uncontrolled, phase 1 trial
Affiliation:1. The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK;2. Institute of Virology, Philipps University of Marburg, Marburg, Germany;3. German Center for Infection Research, Thematic Translational Unit Emerging Infections, Marburg, Germany;4. International Vaccine Institute, Science Unit, Seoul, South Korea
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号